Trading Summary - December 22. Yet another satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
146
Trading Summary - December 22.

Yet another satisfactory status quo day for $DIGX.

The usual insignificant paint downs from bashers at the open - and possibly one very small holder selling later - enabled only 2M to be bought on the bid today at .0003.

208M bought at .0003 since August 23 - the majority by longs building an inventory of shares to be traded on the several runs that are likely to come in 2018.

All followers of $DIGX here have no excuse for not being set up for 2018 now. There has been ample opportunity to load a combination of .0003s and .0004s for 18 weeks - with .0004s being the only realistic option left now for any significant amount.

Anyone who wants .0004s - because the likelihood of getting any meaningful quantity of .0003s is limited in the 4 remaining trading days in 2017 - better not wait too long. Once we get into the new tax year, the .0004s could get taken out in seconds / minutes setting off a run - just like happened to the year start ask at the beginning of 2017.

In addition, in 2017, PRs came out in both Jan and Feb.

As always, anything could happen at anytime. So stay sharp if you don't already have all the shares you need to make your profit expectations up to Q4 in March 2018 and thereafter in 2018. Prior warning and / or scanner alerts of any significant buys starting a run up will not be given on iHub but they will be alerted here immediately.

Content below the line mainly unchanged from last update - relevant to those that are new here.

The PR associated with the 2017 Q3 - that was filed on November 16 - has not been issued yet. The PR associated with 2016 Q3 came out on December 12, 2016 - see here:

http://www.otcmarkets.com/stock/DIGX/news/DIG...08&b=y

Until the PR comes out highlighting the excellent results - and hopefully also updating future brand expansion plans - only those who were looking for the Q3 - who mostly already have their shares - have seen it.

http://www.otcmarkets.com/stock/DIGX/news/DIG...08&b=y

In due course, the Q4 results will speak for themselves and - when PR'ed to the wider investing community - we should see serious additional new interest due to the low O/S and relatively high positive revenue for a stock in this price range - just as happened for the 2016 Q4 and the 2017 Q1 and Q2. In addition, those reluctant to buy on the ask whilst they think they still have a chance of filling on the bid before the Q4 will probably change their mind in January - ask buying started on January 13 at the beginning of this year.

As previously stated, the large additional share retirement of 275M shares since Jul 31 - on top of the 150M retired Dec 2016 > May 2017 making 425M total - has not been PR'ed yet either.

Excellent update recently on the Verified Company Profile share structure at otcmarkets.com from the Transfer Agent (see new sticky #1902) - this has not been PR'ed yet to the wider investing community and has not been spotted by the inattentive on iHub:

O/S and A/S confirmed unchanged as at Nov 30, 2017.

Float same as for all the runs this year - 50M reduction since Dec 2016.

Another 275M shares retired between Jul 31 and Oct 31 (as promised).

That takes total retired to 425M since May 31 - a significant reduction on such a small A/S and O/S for a stock in this price range.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs during the remainder of 2017 (there is usually a Q4 estimate + plans update in December) and throughout 2018. It is already known from posted comments and observation that at least 4 of the main whales are buying shares - on the bid and on the ask - from the impatient at year end.

As predicted, at least 4 x whales who trade $DIGX continuously throughout each year were happy to take around 100M at .0003 when a few impatient people decided to trade for a loss at .0003 on December 14.

The big boys in DIGX now probably already have an inventory of 50M>200M each for trading through to end-2017 and up to the 2017 Q4 in March 2018.

Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q4. Shares bought at .0005 should easily return 100%+ at some point in 2018.

In my experience, 70M>100M (or 250M at year end for the next year) is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year highs will not require any shares bought above .0003 now so all others will be tradeable going forward.

As expected, the status quo has been pretty much maintained throughout the inter Q2/Q3 PR period with it making little difference to long-term traders whether shares are picked up at .0003/4/5/6 - they will see a profit on all of them by Q4 and on various runs between.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan announced earlier - over the coming days, weeks and months..

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>200M shares at these end-2017 prices to trade over the next 12 months if there was even the remote possibility of a reverse split.

There have never been any promotion campaigns on $DIGX in the modern era on the current business model - since the acquisition of Expressions Chiropractic & Rehab in January 2016 and I don't think there will be any. The PRs alone + OTC market off-the-bottom specialists spotting the loading on scanners, keeping accurate records and networking with other traders has proved sufficient to generate multiple runs in 2017 and should do the same in future throughout 2018.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small). It remains the top earner in 2017.

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.





American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rain Agent Vaults: Revolutionizing Payments with AI

Updated Category News Views 123

Innovative Payments with AI Power Alright, folks, Rain's gone and done something that's probably going to shake things up in the payments world—'cause they've given AI agents the ability to handle money like never before. We're not just talking about some run-of-the-mill integration here. This is a genuine game changer, promising to make agents as financially savvy as...

Continue Reading
ProBio, AbTis Forge Bond for Next-Gen Oncology ADCs

Updated Category News Views 99

Deal or No Deal: ProBio's New Licensing Agreement In the ever-evolving realm of biopharmaceuticals, ProBio's recent handshake with South Korea's AbTis is stirring the pot. The shot-callers at ProBio are passing the baton to AbTis, giving them a crack at developing a thumping new therapeutic antibody asset aimed squarely at oncology targets. Pretty slick move if you ask...

Continue Reading
Alogent's Unify Snags Award for Innovation and Impact

Updated Category News Views 104

Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 122

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
FirstDigital Expands Fiber Network in Utah and Arizona

Updated Category News Views 86

Weaving a Web of Connectivity Let's talk about FirstDigital putting its shoulder to the wheel in Utah and Arizona. They're expanding their redundant fiber network to rope in more businesses under their umbrella of connectivity. This ain't just another dry IT endeavor—it's about building a safety net for our ever-connected world. The Stakes of Network Disruption You know...

Continue Reading
Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Updated Category News Views 73

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Continue Reading
Alyssa Bunch: Big Moves in Tennessee Real Estate

Updated Category News Views 104

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Continue Reading
Bakersfield Sees Spike in Crashes Post Time Change

Updated Category News Views 83

Evening Darkness and Safety Concerns Folks, it seems Bakersfield streets transform into a battlefield once the clock falls back. With darkness creeping in earlier, those evening hours right after the time change see a sobering uptick in accidents. According to an analysis by Chain | Cohn | Clark, pedestrian and bicyclist crashes from 5 to 7 p.m. double. It's not just...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 5

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Zephyr's Alto Hood: Redefining Kitchen Versatility

Updated Category News Views 75

An Artist in the Kitchen Who knew a kitchen hood could be a canvas, right? Zephyr, always a punch above the ordinary in kitchen design, has pulled another rabbit out of their hat with the Alto Wall Custom Hood. Forget blending in; this piece is about standing out and shouting style—all while keeping your cooking area fresh. Options Galore The Alto Hood isn't about...

Continue Reading

Top 5 Most Recently Viewed Articles

Constellation Brands Schedules Earnings Call for Q2 2026

Updated Category News Views 395

Constellation Brands Sets New Reporting Date Constellation Brands, Inc. (NYSE: STZ), a prominent player in the beverage alcohol sector, has recently revised its reporting schedule for the financial results of its second quarter, which ended on August 31, 2025. The new reporting date is set for October 6, 2025, after the markets close. Investors and analysts will be able...

Continue Reading
Bullish Trends Continue for Charter Communications in Options Market

Updated Category News Views 212

Analyzing the Recent Options Trends of Charter Communications The options market is bustling with activity around Charter Communications, indicating a strong bullish sentiment. Investors with significant capital are positioning themselves favorably, potentially anticipating upward price movements for the stock, CHTR. Summary of Options Trading Activity Examining the...

Continue Reading
California Water Service Group's Insights on Sustainability Efforts

Updated Category News Views 386

California Water Service Group Advances Sustainability Initiatives In its latest report, California Water Service Group (NYSE: CWT) has unveiled significant progress on various sustainability efforts aimed at minimizing its environmental footprint and enhancing corporate responsibility. This comprehensive overview showcases the Group's dedication to maintaining high...

Continue Reading
Deadline Approaches for Outset Medical Class Action Investors

Updated Category News Views 50

Important Deadline for Outset Medical Investors Investors, it’s time to stay alert! There’s an upcoming deadline that you need to be aware of regarding the class action lawsuit against Outset Medical, Inc. This lawsuit concerns investors who purchased or acquired securities of Outset Medical during a specific period. With the deadline looming, many individuals may be...

Continue Reading
Investors Losing from ASML Holding N.V. Should Seek Justice

Updated Category News Views 145

Investors' Alert: Class Action Against ASML Holding N.V. ASML Holding N.V. (NASDAQ: ASML) is currently facing a class action securities lawsuit that aims to defend the interests of its investors who may have suffered financial losses. This legal move is significant, especially for those who have been adversely affected by certain events within the semiconductor industry....

Continue Reading